Clinical trial
Platelets and Complement Activation in Coronary Artery Bypass Graft Surgery (CABG)
NCT05033236 is registered in ClinicalTrials.gov with Medical University Innsbruck as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Platelets and Complement Activation in Coronary Artery Bypass Graft Surgery (CABG)
- Lead sponsor
- Medical University Innsbruck
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 23, 2018
- Completion date
- July 30, 2022
- Enrollment
- 190 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiopulmonary bypass, inflammatory response, platelet dysfunction